Cancellation of stock options under the stock option incentive plan for Li Zhu Medicine (01513.HK) in 2022.

Zhixun Finance APP News, Lijun Pharmaceutical (01513.HK) announced that on April 23, 2025, the company plans to cancel 384,045 stock options that have not yet been exercised in the first exercise period of the first grant of stock options, 5,283,750 stock options corresponding to the third exercise period of the first grant of stock options, and reserve 1,000,000 stock options corresponding to the second exercise period of the granted stock options.